NEOS Investment Management LLC Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

NEOS Investment Management LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 30.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,744 shares of the company's stock after purchasing an additional 2,487 shares during the period. NEOS Investment Management LLC's holdings in HCA Healthcare were worth $3,225,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. UniSuper Management Pty Ltd boosted its holdings in shares of HCA Healthcare by 4.6% in the fourth quarter. UniSuper Management Pty Ltd now owns 59,310 shares of the company's stock worth $17,802,000 after acquiring an additional 2,616 shares during the period. WINTON GROUP Ltd bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $270,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in HCA Healthcare by 6.8% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 294,597 shares of the company's stock worth $87,407,000 after acquiring an additional 18,672 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund bought a new position in shares of HCA Healthcare in the fourth quarter worth $840,000. Finally, Woodmont Investment Counsel LLC boosted its stake in HCA Healthcare by 3.8% during the fourth quarter. Woodmont Investment Counsel LLC now owns 58,724 shares of the company's stock valued at $17,626,000 after buying an additional 2,168 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Remove Ads

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Up 0.2 %

Shares of HCA stock traded up $0.79 during midday trading on Wednesday, reaching $346.52. 315,697 shares of the stock were exchanged, compared to its average volume of 1,344,416. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The firm has a market cap of $85.31 billion, a PE ratio of 15.77, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company's 50 day moving average is $325.79 and its two-hundred day moving average is $340.25.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the firm posted $5.90 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research analyst reports. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald reissued an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. KeyCorp reduced their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Finally, Morgan Stanley cut their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.